Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials, 33(2), 386-95. presented at the 2012 Mar. doi:10.1016/j.cct.2011.11.001. (2012).
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemp Clin Trials, 33(1), 197-205. presented at the 2012 Jan. doi:10.1016/j.cct.2011.09.018. (2012).
Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. Contemp Clin Trials, 33(5), 993-1002. presented at the 2012 Sep. doi:10.1016/j.cct.2012.05.003. (2012).
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials, 39(2), 211-23. presented at the 2014 Nov. doi:10.1016/j.cct.2014.08.011. (2014).
Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry, 171(6), 683-90. presented at the 2014 Jun. doi:10.1176/appi.ajp.2014.13081055. (2014).
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials, 93, 106014. presented at the 2020 Jun. doi:10.1016/j.cct.2020.106014. (2020).